US researchers recycle kidneys to solve donor organ shortage
Friday, 24 May 2013- Researchers at Wake Forest Baptist Medical Center and colleagues, reporting in the journal Biomaterials, found that human kidneys discarded for transplant can potentially serve as a natural "scaffolding material" for manufacturing replacement organs in the lab using...
Posted by: JV
Male chronic pelvic pain syndrome and the role of interdisciplinary pain management
Thursday, 23 May 2013- A.Baranowswki and colleagues published a report in the World Journal of Urology regarding chronic pelvic pain treatment for men.
The study is a team collaboration which aims to describe the multidisciplinary chronic pelvic pain (CPP) service for men in a major London...
Posted by: JV
Patients with BRCA mutations: PARP inhibitor shows benefit in prostate, pancreatic cancers
Wednesday, 22 May 2013- In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
Results of...
Posted by: JV
Urinary high molecular weight matrix metalloproteinases: non-invasive biomarker for detecting bladder cancer
Tuesday, 21 May 2013- Matrix Metalloproteinases (MMPs) are key molecules for tumor growth, invasion and metastasis. Over-expression of different MMPs in tumor tissues can disturb the homeostasis and increase the level of various body fluids. Many MMPs including high molecular weights (HMWs) were...
Posted by: JV
Assessing comorbidities recommended before prostate biopsy
Monday, 20 May 2013- UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities - the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) and the physician-reported Charlson Comorbidity Index -...
Posted by: JV
Xofigo to treat bone mets from prostate cancer gets FDA approval
Friday, 17 May 2013- The US Food and Drug Administration (FDA) has approved radium-223 dichloride (Xofigo) for treating bone metastases from castration-resistant prostate cancer, the agency announced. Its specific indication is for men with symptomatic, late-stage, castration-resistant...
Posted by: JV
Study evaluates long-term effectiveness of surgery for pelvic organ prolapse
Thursday, 16 May 2013- Results after seven years of follow-up suggest that women considering abdominal sacrocolpopexy (surgery for pelvic organ prolapse [POP]) should be counseled that this procedure effectively provides relief from POP symptoms.
However, the anatomic support deteriorates over...
Posted by: JV
New PCa tool developed by US team helps identify men suited for active surveillance
Wednesday, 15 May 2013- A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.
The test, which improves risk assessment when patients are first diagnosed, can also aid in...
Posted by: JV
Bladder cancer gets low priority in UK despite prevalence
Tuesday, 14 May 2013- It is the 4th most common cancer in men and 11th in women, but bladder cancer remains an extremely low priority in the UK. Action on Bladder Cancer[(ABC) reports that almost half (45%) of the UK public do not know that even just one episode of blood in the urine, the most...
ASTRO, AUA issue joint guidelines for radiation therapy after prostatectomy
Monday, 13 May 2013- The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.
The...
Posted by: JV
